Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This combination drug is a fixed-dose formulation consisting of two standardized botanical extracts, *Panax ginseng* and *Ginkgo biloba*, along with a comprehensive complex of multivitamins and polyminerals. It is primarily developed for the treatment of cognitive function disorders and memory deficits. *Ginkgo biloba* extract acts as a vasodilator and a platelet-activating factor (PAF) receptor antagonist, which enhances cerebral blood flow and provides neuroprotective antioxidant effects. *Panax ginseng* serves as an adaptogen that modulates the hypothalamic-pituitary-adrenal (HPA) axis and GABAergic systems to improve mental resilience and cognitive performance. The multivitamin and polymineral components provide essential micronutrients that serve as enzymatic cofactors in neuronal energy metabolism and cellular maintenance. The Brazilian pharmaceutical company EMS sponsored clinical research into this specific combination, although some trials were withdrawn before completion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on panax ginseng + ginkgo biloba + multivitamin + polyminerals.